At a glance
ClinicalIndex Comparison RecordN/ACompleted· 21 enrolled
Drug / intervention
Duloxetine +1 moredrug
Likely dose
Duloxetine 30mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Brain Morphometric Study in Knee Osteoarthritis Patients Treated With Duloxetine
In Brief
A clinical study evaluating Duloxetine and Placebo Oral Tablet for Pain and Osteoarthritis. Completed, enrolled 21 participants across 1 site.
Detailed Summary
This is a two week,single-blind study evaluating pain response and changes in brain imaging upon treatment with placebo in people with knee OA.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Osteoarthritis
CountriesUnited States
CollaboratorsEli Lilly and Company
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2011
Primary CompletionOct 2011
Study CompletionDec 2011
First PostedSep 2016
TodayJul 2026
First PostedSep 16, 2016
Enrollment StartJul 1, 2011
Primary CompletionOct 1, 2011
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.8 years ago
Interventions
Duloxetinedrug
Duloxetine Delayed-Release Capsules: 30mg/day for 1 week ; 60mg/day for the remaining time
Placebo Oral Tabletdrug
Lactose capsule